Trial Profile
An Extended Follow up of a Phase 2b Vaccine Trial With RTS,S/AS01E in Kilifi District, Kenya [EXTENSION OF 700018166].
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Malaria vaccine (Primary) ; Rabies vaccine
- Indications Malaria
- Focus Therapeutic Use
- 30 Jun 2016 Results assessing seven year efficacy published in the New England Journal of Medicine.
- 23 Jul 2014 Planned End Date changed from 1 Aug 2013 to 1 Aug 2016 as reported by ClinicalTrials.gov record.
- 23 Jul 2014 Planned primary completion date changed from 1 Feb 2013 to 1 Feb 2016 as reported by ClinicalTrials.gov record.